After the first seed concept introduced in the 18th century, different disciplines have attributed different names to dual-functional molecules depending on their application, including bioconjugates, bifunctional compounds, multitargeting molecules, chimeras, hybrids, engineered compounds. However, these engineered constructs share a general structure: a first component that targets a specific cell and a second component that exerts the pharmacological activity. A stable or cleavable linker connects the two modules of a chimera. Herein, we discuss the recent advances in the rapidly expanding field of chimeric molecules leveraging chemical biology concepts. This Perspective is focused on bifunctional compounds in which one component is a lead compound or a drug. In detail, we discuss chemical features of chimeric molecules and their use for targeted delivery and for target engagement studies.
Designing Chimeric Molecules for Drug Discovery by Leveraging Chemical Biology / Borsari, C.; Trader, D. J.; Tait, A.; Costi, M. P.. - In: JOURNAL OF MEDICINAL CHEMISTRY. - ISSN 0022-2623. - 63:5(2020), pp. 1908-1928. [10.1021/acs.jmedchem.9b01456]
Designing Chimeric Molecules for Drug Discovery by Leveraging Chemical Biology
Tait A.Methodology
;Costi M. P.
Funding Acquisition
2020
Abstract
After the first seed concept introduced in the 18th century, different disciplines have attributed different names to dual-functional molecules depending on their application, including bioconjugates, bifunctional compounds, multitargeting molecules, chimeras, hybrids, engineered compounds. However, these engineered constructs share a general structure: a first component that targets a specific cell and a second component that exerts the pharmacological activity. A stable or cleavable linker connects the two modules of a chimera. Herein, we discuss the recent advances in the rapidly expanding field of chimeric molecules leveraging chemical biology concepts. This Perspective is focused on bifunctional compounds in which one component is a lead compound or a drug. In detail, we discuss chemical features of chimeric molecules and their use for targeted delivery and for target engagement studies.File | Dimensione | Formato | |
---|---|---|---|
proof-2.pdf
Open access
Descrizione: Articolo principale
Tipologia:
Versione dell'autore revisionata e accettata per la pubblicazione
Dimensione
4.97 MB
Formato
Adobe PDF
|
4.97 MB | Adobe PDF | Visualizza/Apri |
acs.jmedchem.9b01456.pdf
Open access
Tipologia:
Versione pubblicata dall'editore
Dimensione
4.79 MB
Formato
Adobe PDF
|
4.79 MB | Adobe PDF | Visualizza/Apri |
Pubblicazioni consigliate
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris